Vericel share price today

(VCEL)

Vericel share price is $56.5 & ₹4,801.14 as on 21 Dec 2024, 2.30 'hrs' IST

$56.5

▲

1.55

(2.82%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Vericel share price in Dollar and Rupees. Guide to invest in Vericel from India. Also see the sentimental analysis on Indian investors investing in Vericel. Get details on the Indian mutual funds that are investing in Vericel. Get Analyst recommendations and forecasts along with all the Vericel's financials.

Vericel share price movements

Today's Low: $54.32
Today's High: $57.22
$56.50
3.86%
Downside
Day's Volatility :5.07%
Upside
1.26%
52 Weeks Low: $32.31
52 Weeks High: $61.49
$56.50
42.81%
Downside
52 Weeks Volatility :47.45%
Upside
8.12%

Vericel Returns

Period	Vericel Corporation	Sector (Health Care)	Index (Russel 2000)
3 Months	21.85%	-11.1%	0.0%
6 Months	22.32%	-6.0%	0.0%
1 Year	55.6%	2.7%	0.0%
3 Years	35.69%	0.6%	-19.7%

Vericel Key Statistics

in dollars & INR

Previous Close	$54.95
Open	$54.4
Today's High	$57.22
Today's Low	$54.32
Market Capitalization	$2.7B
Today's Volume	$619.0K
52 Week High	$61.49
52 Week Low	$32.31
Revenue TTM	$226.8M
EBITDA	$3.9M
Earnings Per Share (EPS)	$0.08
PE Ratio	686.88
Profit Margin	1.56%
Quarterly Earnings Growth YOY	1.05%
Return On Equity TTM	1.54%

How to invest in Vericel from India?

It is very easy for Indian residents to invest directly in Vericel from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vericel stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vericel or VCEL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vericel or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vericel shares which would translate to 0.015 fractional shares of Vericel as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Vericel, in just a few clicks!

Returns in Vericel for Indian investors in Rupees

Investment Value

₹1,00,000

Vericel investment value today

Current value as on today

₹1,57,801

Returns

₹57,801

(+57.8%)

Returns from Vericel Stock

₹55,605 (+55.6%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Vericel

200%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Vericel on INDmoney from India has grown in the last 30 days as on Dec 22, 2024. 200% more investors are searching Vericel in the last 30 days versus the previous period.

Global Institutional Holdings in Vericel

BlackRock Inc
16.32%
Brown Capital Management, LLC
7.75%
Vanguard Group Inc
7.06%
State Street Corp
4.92%
FMR Inc
4.81%
Amvescap Plc.
4.80%

Analyst Recommendation on Vericel

Buy

91%Buy

8%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Vericel(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Vericel

What analysts predicted

Upside of 13.72%

Current:

$56.50

Target:

$64.25

Insights on Vericel

Price Movement
In the last 3 months, VCEL stock has moved up by 21.3%
Increasing Revenue
Revenue is up for the last 3 quarters, 51.28M → 57.90M (in $), with an average increase of 5.8% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -4.68M → -901.0K (in $), with an average increase of 419.6% per quarter

Vericel Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$90.9M	↑ 42.13%
Net Income	$-8.1M	↓ 52.93%
Net Profit Margin	-8.96%	↑ 18.08%

	FY19	Y/Y Change
Revenue	$117.9M	↑ 29.71%
Net Income	$-7.9M	↓ 2.8%
Net Profit Margin	-6.71%	↑ 2.25%

	FY20	Y/Y Change
Revenue	$124.2M	↑ 5.37%
Net Income	$2.9M	↓ 136.21%
Net Profit Margin	2.31%	↑ 9.02%

	FY21	Y/Y Change
Revenue	$156.2M	↑ 25.77%
Net Income	$-7.5M	↓ 360.86%
Net Profit Margin	-4.78%	↓ 7.09%

	FY22	Y/Y Change
Revenue	$164.4M	↑ 5.24%
Net Income	$-16.7M	↑ 123.65%
Net Profit Margin	-10.17%	↓ 5.39%

	FY23	Y/Y Change
Revenue	$197.5M	↑ 20.17%
Net Income	$-3.2M	↓ 80.96%
Net Profit Margin	-1.61%	↑ 8.56%

	Q2 FY23	Q/Q Change
Revenue	$45.9M	↑ 11.96%
Net Income	$-5.0M	↓ 20.78%
Net Profit Margin	-10.93%	↑ 4.52%

	Q3 FY23	Q/Q Change
Revenue	$45.6M	↓ 0.74%
Net Income	$-3.7M	↓ 27.09%
Net Profit Margin	-8.03%	↑ 2.9%

	Q4 FY23	Q/Q Change
Revenue	$65.0M	↑ 42.59%
Net Income	$13.0M	↓ 455.0%
Net Profit Margin	19.99%	↑ 28.02%

	Q1 FY24	Q/Q Change
Revenue	$51.3M	↓ 21.1%
Net Income	$-3.9M	↓ 129.72%
Net Profit Margin	-7.53%	↓ 27.52%

	Q2 FY24	Q/Q Change
Revenue	$52.7M	↑ 2.69%
Net Income	$-4.7M	↑ 21.23%
Net Profit Margin	-8.89%	↓ 1.36%

	Q3 FY24	Q/Q Change
Revenue	$57.9M	↑ 9.96%
Net Income	$-901.0K	↓ 80.76%
Net Profit Margin	-1.56%	↑ 7.33%

	FY18	Y/Y Change
Profit	$58.7M	↑ 74.85%

	FY19	Y/Y Change
Profit	$80.3M	↑ 36.77%

	FY20	Y/Y Change
Profit	$84.2M	↑ 4.92%

	FY21	Y/Y Change
Profit	$106.0M	↑ 25.88%

	FY22	Y/Y Change
Profit	$109.8M	↑ 3.55%

	FY23	Y/Y Change
Profit	$135.6M	↑ 23.49%

	Q2 FY23	Q/Q Change
Profit	$29.9M	↑ 12.9%

	Q3 FY23	Q/Q Change
Profit	$30.6M	↑ 2.23%

	Q4 FY23	Q/Q Change
Profit	$48.5M	↑ 58.48%

	Q1 FY24	Q/Q Change
Profit	$35.4M	↓ 27.12%

	Q2 FY24	Q/Q Change
Profit	$36.6M	↑ 3.53%

	Q3 FY24	Q/Q Change
Profit	$41.7M	↑ 13.8%

	FY18	Y/Y Change
Operating Cash Flow	$-412.0K	↓ 96.87%
Investing Cash Flow	$-67.0M	↑ 4338.87%
Financing Cash Flow	$58.9M	↑ 216.86%

	FY19	Y/Y Change
Operating Cash Flow	$-7.2M	↑ 1643.45%
Investing Cash Flow	$10.6M	↓ 115.84%
Financing Cash Flow	$5.3M	↓ 91.06%

	FY20	Y/Y Change
Operating Cash Flow	$17.6M	↓ 344.63%
Investing Cash Flow	$-17.2M	↓ 261.66%
Financing Cash Flow	$6.4M	↑ 22.45%

	FY21	Y/Y Change
Operating Cash Flow	$29.0M	↑ 65.26%
Investing Cash Flow	$-3.5M	↓ 79.6%
Financing Cash Flow	$9.2M	↑ 42.38%

	FY22	Y/Y Change
Operating Cash Flow	$17.7M	↓ 39.09%
Investing Cash Flow	$-36.2M	↑ 934.16%
Financing Cash Flow	$1.0M	↓ 88.61%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$10.2M	↑ 29.72%
Investing Cash Flow	$-2.4M	↓ 186.0%
Financing Cash Flow	$1.2M	↑ 1016.82%

Vericel Technicals Summary

Sell

Neutral

Buy

Vericel is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Vericel Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Vericel Corporation	-4.42%	22.32%	55.6%	35.69%	217.59%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Vericel Corporation	686.88	686.88	0.0	0.14	0.02	0.0	NA	5.23
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Vericel Corporation	Buy	$2.7B	217.59%	686.88	1.56%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

About Vericel

about vericel founded in 1989, vericel (formerly aastrom biosciences), is dedicated to the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. the company markets two cell therapy products in the united states, carticel® (autologous cultured chondrocytes), an autologous chondrocyte implant for the treatment of cartilage defects in the knee and epicel® (cultured epidermal autografts), a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. vericel is also developing maci, a third-generation autologous chondrocyte implant for the treatment of cartilage defects in the knee, and ixmyelocel-t, a patient specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy (dcm). to fulfill vericel’s mission of helping people with severe diseases and conditions rea

Organization	Vericel
Employees	314
CEO	Mr. Dominick C. Colangelo Esq.
Industry	Health Technology

Management People of Vericel

Name	Title
Mr. Dominick C. Colangelo Esq.	CEO, President & Director
Mr. Joseph Anthony Mara Jr.	CFO & Treasurer
Mr. Michael Halpin	Chief Operating Officer
Mr. Sean C. Flynn	Chief Legal Officer
Dr. Jonathan M. Hopper FRCSEd., M.B. Ch.B.	Chief Medical Officer
Mr. Jonathan D. Siegal	Principal Accounting Officer, VP & Corporate Controller
Mr. Eric Burns	Vice President of Finance & Investor Relations
Mr. Patrick J. Fowler	Senior Vice President of Corporate Development & Strategy
Mr. Patrick Helfrich	Vice President of Marketing & Commercial Strategy
Mr. Mike Gilligan	Senior Vice President of Sales

Important FAQs about investing in Vericel from India :

What is Vericel share price today?

Vericel share price today stands at $56.50, Open: $54.40 ; Previous Close: $54.95 ; High: $57.22 ; Low: $54.32 ; 52 Week High: $61.49 ; 52 Week Low: $32.31. The stock opens at $54.40, after a previous close of $54.95. The stock reached a daily high of $57.22 and a low of $54.32, with a 52-week high of $61.49 and a 52-week low of $32.31.

Can Indians buy Vericel shares?

Yes, Indians can invest in the Vericel (VCEL) from India.

With INDmoney, you can buy Vericel at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Vericel at zero transaction cost.

How can I buy Vericel shares from India?

It is very easy to buy Vericel from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vericel be purchased?

Yes, you can buy fractional shares of Vericel with INDmoney app.

What are the documents required to start investing in Vericel stocks?

To start investing in Vericel, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.